EU concludes COVID-19 vaccine talks with Pfizer

10-09-2020

Sarah Morgan

EU concludes COVID-19 vaccine talks with Pfizer

StockStudio / Shutterstock.com

The European Commission has concluded exploratory talks with Pfizer and BioNTech to potentially supply 300 million doses of their investigational vaccine against COVID-19.


European Commission, EU, COVID-19, vaccine, investigational vaccine, COVID-19 vaccine, coronavirus, Pfizer, BioNTech

LSIPR